Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.9209.9688
Address
Unit 1 31 Sabre Drive Port Melbourne, Victoria (VIC) 3207
Description
Austco Healthcare Ltd. engages in the development, manufacture, and supply of hardware relating to healthcare and electronic communications systems. It operates through the following geographical segments: Australia/New Zealand, Asia, Europe, and North America. The company was founded by Robert Edward Grey in 2004 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.2 - 0.4
Trade Value (12mth)
AU$18,999.00
1 week
1.35%
1 month
-1.32%
YTD
27.12%
1 year
78.57%
All time high
0.79
EPS 3 yr Growth
94.20%
EBITDA Margin
13.90%
Operating Cashflow
$11m
Free Cash Flow Return
32.10%
ROIC
20.00%
Interest Coverage
54.40
Quick Ratio
1.80
Shares on Issue (Fully Dilluted)
370m
HALO Sector
Industrials
Next Company Report Date
N/A
Ex Dividend Date (est.)
02-Mar-23
Next Dividend Pay Date (est.)
05-Apr-23
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
26 August 25 |
Appendix 4E & FY25 Financial Statements
×
Appendix 4E & FY25 Financial Statements |
26 August 25 |
Austco FY25 Results Media Release
×
Austco FY25 Results Media Release |
26 August 25 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
04 August 25 |
Application for quotation of securities - AHC
×
Application for quotation of securities - AHC |
31 July 25 |
Application for quotation of securities - AHC
×
Application for quotation of securities - AHC |
31 July 25 |
Change of Director's Interest Notice - Astles
×
Change of Director's Interest Notice - Astles |
23 July 25 |
Austco Healthcare Trading Update and Guidance Upgrade
×
Austco Healthcare Trading Update and Guidance Upgrade |
17 July 25 |
Application for quotation of securities - AHC
×
Application for quotation of securities - AHC |
08 July 25 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
30 May 25 |
Austco completes acquisition of NZ based G&S Technologies
×
Austco completes acquisition of NZ based G&S Technologies |
14 May 25 |
Secures $2.1M contract at Toronto Western Hospital
×
Secures $2.1M contract at Toronto Western Hospital |
09 May 25 |
Signs Agreement with Leading US Healthcare Provider
×
Signs Agreement with Leading US Healthcare Provider |
16 April 25 |
Austco Healthcare awarded $3.4m contract with Angeles Health
×
Austco Healthcare awarded $3.4m contract with Angeles Health |
09 April 25 |
Austco enters binding term sheet to acquire G&S Technologies
×
Austco enters binding term sheet to acquire G&S Technologies |
01 April 25 |
Change of Director's Interest Notice - Astles
×
Change of Director's Interest Notice - Astles |
27 March 25 |
Teknocorp Earn-Out Payment, Release of Escrow Shares
×
Teknocorp Earn-Out Payment, Release of Escrow Shares |
21 March 25 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
18 March 25 |
Austco Secures Largest SMA Contract in Company History
×
Austco Secures Largest SMA Contract in Company History |
17 March 25 |
Austco Healthcare Investor Presentation
×
Austco Healthcare Investor Presentation |
11 March 25 |
Notification of cessation of securities - AHC
×
Notification of cessation of securities - AHC |
11 March 25 |
Change of Director's Interest Notice - Burns
×
Change of Director's Interest Notice - Burns |
27 February 25 |
Austco Healthcare Appendix 4D and HY Dec 24 Results
×
Austco Healthcare Appendix 4D and HY Dec 24 Results |
27 February 25 |
Austco Healthcare HY Dec 24 Results Media Release
×
Austco Healthcare HY Dec 24 Results Media Release |
02 January 25 |
Details of Company Address
×
Details of Company Address |
18 December 24 |
First Half FY25 trading update
×
First Half FY25 trading update |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.